Michelle opens with a welcome and introduction before diving into the ongoing debate surrounding open-source AI and recent industry updates. The episode covers Tempus AI's acquisition of Ambry Genetics, highlighting its implications for the healthcare sector. Michelle discusses the UK's launch of a new AI trust platform and the significant valuation surge of Perplexity AI. Microsoft's development of the Magnetic-One multi-agent AI and its enhancements to Windows software are explored. The episode also examines the changes in AI regulation under the Trump administration, providing context and insights into the evolving landscape of AI governance.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related